Spectator on facebook

Spectator on facebook


Biotika sacks leadership due to poor 1997 results

After Biotika, Slovakia's largest antibiotics producer, saw a 130 million Sk loss last year, the company decided to change its management on February 6. The huge drop in profits is attributed to a drastic fall in world prices of penicillin, Biotika's main product. Due to the fall, the company lost 300 million Sk. Since two thirds of company's capacity is tied to biotechnological and fermentation production, not even a 100 percent increase in other production could cover the soaring deficit gap. Miroslav Otčenáš, Biotika's new general director, and Jozef Ďuriš, the new economic director, therefore announced a substantial restructuring in the company's product portfolio. In 1992, over 59 percent of Biotika was privatized in a voucher privatization, but the controlling package was sold in February 1996 to G.V. Pharma, a company with strong personnel ties to Slovakofarma, a pharmaceutical giant.

Top stories

Press freedom is bleeding across our borders

Critical media are always the first targets of populists and press freedom enemies.

I have met dozens of people possessed by Satan, exorcist claims

An exorcist can help a believer to escape their problems but not to solve them, psychiatrist Hunčík says.

Priest and exorcist Ľuboš Václavek consecrates the office of Erika Jurinová (OĽaNO).

End of investigative show a cause for concern

Media freedom watchdogs believe the scrapping of the only investigative show on public-service television is a threat to its independence.

Jaroslav Rezník

Slovakia is 26th on the Employment Flexibility Index

Higher work surcharges will push Slovakia down.